Page last updated: 2024-11-03

riluzole and Pain, Postoperative

riluzole has been researched along with Pain, Postoperative in 1 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Pain, Postoperative: Pain during the period after surgery.

Research Excerpts

ExcerptRelevanceReference
" Adverse events were analysed in the modified intention-to-treat (mITT) population, defined as all patients who underwent randomisation, including those who did not ultimately undergo surgical decompression."3.01Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. ( Ahn, H; Arnold, PM; Badhiwala, JH; Brodke, DS; Farhadi, HF; Fehlings, MG; Fourney, DR; Harrop, JS; Hilibrand, AS; Jacobs, WB; Kelly, M; Kim, KD; Kopjar, B; Massicotte, EM; Mummaneni, P; Nassr, A; Riew, KD; Santaguida, C; Shaffrey, CI; Vaccaro, AR; Wilson, J; Yoon, ST, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fehlings, MG1
Badhiwala, JH1
Ahn, H1
Farhadi, HF1
Shaffrey, CI1
Nassr, A1
Mummaneni, P1
Arnold, PM1
Jacobs, WB1
Riew, KD1
Kelly, M1
Brodke, DS1
Vaccaro, AR1
Hilibrand, AS1
Wilson, J1
Harrop, JS1
Yoon, ST1
Kim, KD1
Fourney, DR1
Santaguida, C1
Massicotte, EM1
Kopjar, B1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy of Riluzole in Patients With Cervical Spondylotic Myelopathy Undergoing Surgical Treatment. A Randomized, Double-Blind, Placebo-controlled Multi-Center Study[NCT01257828]Phase 3270 participants (Actual)Interventional2012-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for riluzole and Pain, Postoperative

ArticleYear
Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
    The Lancet. Neurology, 2021, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cervical Vertebrae; Combined Modality Therapy; Decompres

2021